I was trained in pharmaceutical sciences and in medicine with extensive research experience in the field of molecular biology/pharmacology, oncology and immunology. In recent years, my major research interests are cancer molecular biology, cancer chemotherapy and prevention as well as immunology and autoimmune/autoinflammatory diseases. I am one of founders of Natrogen Therapeutics International, and a chief scientist and president of the company with an adjunct position at New York University School of Medicine since December 2006. I was an assistant professor at the New York University School of Medicine from 2003 to 2006 and at the Mount Sinai School of Medicine from 1996 to 2003. My postdoctoral training was at Brookhaven National Laboratory, and the Roswell Park Cancer Institute. I published over 60 peer-reviewed papers in scientific journals most of which I was listed as a senior author, appeared as a speaker at symposiums, and granted 6 patents in treating autoinflammatory diseases and cancer while many other patents are currently in pending.